ARTICLE | Company News
Berlex gets approvable letter for Bonefos
January 7, 2005 8:00 AM UTC
Berlex received an approvable letter from FDA for Bonefos clodronate as an adjuvant treatment for reducing the occurrence of bone metastases in stage II/III breast cancer patients. The company said it...